Kite, a Gilead company, is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer. With an unrelenting drive and a singular focus on cell therapy, this session will explore how the team is executing a personalized medicine strategy to bring life-saving therapies to patients through a flawless supply chain. There is no margin for error in the end-to-end supply chain process as the patient is not given a second chance.
Understand cryogenic cold chain’s complexity with respect to products, integrity, temperature, label adhesion, and relationships with third party logistics partners
Achieve complete end-to-end visibility from shipping to delivery and secure the chain of custody
Reduce risk of CAR T-cell therapy to a comfortable level and overcome unique challenges
Check out the incredible speaker line-up to see who will be joining Reggie.